FindTrial
Sign In

Platelet Rich Plasma for improving reduced ovarian function, ovarian failure and thinning of uterine lining

Platelet Rich Plasma(PRP)for Endometrial Regeneration and repair and Ovarian rejuvenation in premature ovarian failure - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/04/013006
Enrollment
100
Registered
2018-04-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Premature ovarian failure,infertility,thin endometrium,secondary amenorrhea

Interventions

Intervention1: Platelet Rich Plasma: Collection of Blood sample,processing sample into PRP,instillation of PRP into ovaries by laparoscopy and in endometrium by hysteroscopy Comparator agent- not appl

Sponsors

Dr Manjula Anagani
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Thin endometrium, oligomenorrhea, amenorrhea, low ovarian reserve, premature ovarian failure

Exclusion criteria

Exclusion criteria: Pregnancy,Diagnosis of cancer,Hb

Design outcomes

Primary

MeasureTime frame
To measure the change in endometrial lining thickness,To measure blood flow to zone 3 of endometrium,To determine improvement in ovarian intra stromal blood flow,To assess improvement in FSH levels toward normal ranges Timepoint: Measurements will be done at day 15 and 30 of PRP instillation. Follow up measurement at 3 months.—

Secondary

MeasureTime frame
To determine the rate of return/normalization of menses,To determine clinical pregnancy rate. Timepoint: 2 years—

Countries

India

Contacts

Public ContactDr Prabha Agrawal

Maxcure Hospital

drprabha1001@yahoo.com9849200556

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026